Skip to main content
Log In
Sign Up
Home
Stocks
Stock Screener
Stock Exchanges
Comparison Tool
Earnings Calendar
By Industry
Stock Lists
Top Analysts
Top Stocks
Corporate Actions
IPOs
Recent IPOs
IPO Calendar
IPO Statistics
IPO News
IPO Screener
ETFs
ETF Screener
Comparison Tool
New Launches
ETF Providers
News
Trending
Articles
Technical Chart
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After Hours
Market Heatmap
Market Newsletter
Stock Analysis Pro
Watchlist
Collapse
Beijing Tiantan Biological Products Co., Ltd. (SHA:600161)
China
· Delayed Price · Currency is CNY
Watchlist
Compare
19.73
-0.14 (-0.70%)
Sep 12, 2025, 3:00 PM CST
Overview
Financials
Statistics
Dividends
History
Profile
Chart
Income
Balance Sheet
Cash Flow
Ratios
KPIs
NEW
Annual
Revenue by Product
Fiscal year is January - December.
Download
Full Width
Fiscal Year
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
2005 - 2019
Period Ending
Dec '24
Dec 31, 2024
Dec '23
Dec 31, 2023
Dec '22
Dec 31, 2022
Dec '21
Dec 31, 2021
Dec '20
Dec 31, 2020
2005 - 2019
Intravenous Human Immunoglobulin
2.76B
Log In
Log In
Log In
Log In
Upgrade
Intravenous Human Immunoglobulin Growth
18.90%
Log In
Log In
Log In
Log In
Upgrade
Human Albumin
2.51B
Log In
Log In
Log In
Log In
Upgrade
Human Albumin Growth
11.70%
Log In
Log In
Log In
Log In
Upgrade
Other Blood Products
744.93M
Log In
Log In
Log In
Log In
Upgrade
Other Blood Products Growth
25.10%
Log In
Log In
Log In
Log In
Upgrade
Other
19.11M
Log In
Log In
Log In
Log In
Upgrade
Other Growth
4.01%
Log In
Log In
Log In
Log In
Upgrade
Blood Products
-
Log In
Log In
Log In
Log In
Upgrade
Blood Products Growth
-
Log In
Log In
Log In
Log In
Upgrade
Revenue by Geography
Fiscal year is January - December.
Download
Full Width
Fiscal Year
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
2005 - 2019
Period Ending
Dec '24
Dec 31, 2024
Dec '23
Dec 31, 2023
Dec '22
Dec 31, 2022
Dec '21
Dec 31, 2021
Dec '20
Dec 31, 2020
2005 - 2019
China
6.01B
Log In
Log In
Log In
Log In
Upgrade
China Growth
16.46%
Log In
Log In
Log In
Log In
Upgrade
Foreign
3.70M
Log In
Log In
Log In
Log In
Upgrade
Foreign Growth
76.35%
Log In
Log In
Log In
Log In
Upgrade